Oracle Healthcare AI Boosts Cloud Growth but Supply Challenges Suggest Waiting to Buy

Oracle's latest launch, the Health Clinical AI Agent, marks a notable step in integrating AI into healthcare workflows. This multimodal assistant uses voice and screen inputs to help physicians cut down documentation time by about 30%, addressing a key factor behind clinician burnout.

AI Innovation Driving Healthcare Efficiency

The Health Clinical AI Agent blends generative AI, automation, and streamlined workflows into one tool that works directly with Oracle's electronic health record (EHR) systems. Currently active in 40 medical specialties, it has helped generate nearly a million clinical notes. Providers can retrieve important patient data with simple voice commands, making charting and information access smoother.

Oracle CTO Larry Ellison highlighted this AI development during the recent earnings call, pointing out how the company's AI agents modernize and automate applications, with healthcare being a standout area of impact.

Mixed Financial Signals for Oracle

Oracle's fiscal 2025 third-quarter results showed both promising growth and some setbacks. Total revenues hit $14.1 billion, a 6% increase year-over-year (8% in constant currency). Cloud services and license support grew 12% in constant currency to $11 billion, while cloud infrastructure revenues soared 51%. Remaining performance obligations climbed 63% to $130 billion, a strong indicator of future revenue.

CEO Safra Catz projects revenue growth of 15% for fiscal 2026 and 20% for fiscal 2027. However, non-GAAP earnings of $1.47 per share missed analyst estimates by 0.68%, and total revenues slightly missed expectations by 1.59%. Additionally, cloud license and on-premise license revenues declined 10% year-over-year, signaling challenges in some segments.

Oracle's valuation is currently high, trading at an EV/EBITDA multiple of 21.06x versus the industry average of 16.6x, reflecting investor optimism despite moderate revenue growth.

Cloud Infrastructure Growth Amid Challenges

Oracle's cloud infrastructure business is a strong suit, with OCI consumption revenues up 57%. The company launched its 101st cloud region, potentially outpacing competitors in global cloud presence. Oracle has attracted major tech companies like Advanced Micro Devices, CrowdStrike, and Palo Alto Networks, and its Database@Cloud service grew 200% last quarter.

However, supply chain and component delays have slowed cloud capacity expansion, a concern as competitors accelerate infrastructure build-out to meet AI demand. This bottleneck could impact Oracle’s market share growth at a critical time. Oracle's stock has declined 2.2% year-to-date, underperforming the broader tech sector and the S&P 500.

Investment Outlook: Consider Waiting

While Oracle’s AI and cloud strategies show promise, investors may want to hold off for now. Elevated valuations combined with near-term supply constraints create uncertainty. The backlog of $130 billion offers good visibility into future growth, but component delays have slowed cloud capacity expansion. Oracle expects these issues to ease by the first quarter of fiscal 2026, potentially improving growth later this year.

Capital expenditures are heavy—over $16 billion planned for fiscal 2025—pressuring free cash flow, which declined 53% year-over-year to $5.8 billion due to infrastructure investments. Given these factors, a better entry point could emerge later in 2025 as cloud capacity constraints resolve and AI investments start to pay off.

The long-term outlook remains positive for Oracle’s role in healthcare AI and cloud, but patience may yield more attractive valuations. Currently, Oracle carries a Zacks Rank #3 (Hold).